Tech Transfer Timelines: The Hidden Constraint on Manufacturing Flexibility

Technology transfer remains a critical execution bottleneck in pharmaceutical manufacturing, with biologics requiring 18-24 months and small molecules 6-18 months for standard transfers. While leading organizations are achieving 6-8 month timelines through AI-driven tools and digital twins, adoption remains limited due to regulatory validation requirements, cost barriers, and organizational readiness gaps. This session examines why tech transfer delays prevent access to otherwise available capacity and what early adopters are achieving in 2025-2026.